The World Health Organisation (WHO) has released a public statement regarding the public accessibility of clinical trial results - and has invited a public consultation.
For the next thirty days, the public will be able to comment on this key policy.
This is particularly important in light of the AllTrials Initiative, a coalition effort which encourages the publication and accessibility of all clinical trials results.
"Many AllTrials supporters have wondered why the WHO has never had a policy on reporting the results of clinical trials," says Ian Bushfield of Sense About Science.
If the WHO supports the dissemination of clinical trial research, it would be a victory for transparency in clinical trials.
"This is potentially a really significant step," Bushfield says.
"This policy could provide a global solution."
Interested parties can inform the WHO of their considerations by completing the public feedback form.
ecancermedicalscience accepts submissions of all clinical trials research relating to cancer, including negative trials, and if accepted will publish the results for free.
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.